Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Berti, Sergio
ARMYDA-AMULET, NCT05554822: Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy After Percutaneous Left Atrial Appendage Closure: a Multicenter, Randomized Study	Recruiting	3	574	Europe	Aspirin 100mg, Aspirin 100 mg OD plus clopidogrel 75 mg OD	Azienda Ospedaliero Universitaria Maggiore della Carita, Abbott Medical Devices	Left Atrial Appendage Occlusion, Antiplatelet Therapy	12/23	12/23
NCT04180605: Computational Simulation to Plan for Percutaneous Left Atrial Appendage Closure	Recruiting	N/A	200	Europe, Canada	Additional support for preoperative planning of LAA closure procedures, Left atrial appendage closure	Rigshospitalet, Denmark, Feops, Abbott	Atrial Fibrillation, Stroke Prevention	12/21	12/22
AHEAD, NCT03339115: European Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System	Recruiting	N/A	30	Europe	Cardiovalve Transfemoral Mitral Valve	Cardiovalve Ltd., Meditrial Europe Ltd., Meditrial SrL	Mitral Regurgitation, Mitral Valve Disease	12/24	12/29
CATALYST, NCT04226547: Amplatzer Amulet LAAO Vs. NOAC	Recruiting	N/A	2650	Europe, Canada, Japan, US, RoW	Left Atrial Appendage Occlusion (Amplatzer Amulet LAA Occluder), Amplatzer Amulet LAA Occluder, Non-Vitamin K Oral Antagonists, NOAC	Abbott Medical Devices	Atrial Fibrillation, Stroke, Bleeding	08/27	08/30